EMvision Medical Devices Ltd (ASX: EMV) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


EMvision Medical Devices Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $123.95 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 77.96 million
Earnings per share -0.062
Dividend per share N/A
Year To Date Return -14.05%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • EMvision Medical Devices Ltd (ASX: EMV)
    Latest News

    Three businesspeople leap high with the CBD in the background.
    Earnings Results

    3 ASX shares soaring on earnings updates

    These shares are outperforming on the back of their latest results.

    Read more »

    A smiling woman looks at her computer laptop in her home with warm lights in the background feeling happy to see the EMvision share price rising
    Healthcare Shares

    EMvision share price rockets 11% on $5 million pay day

    Shares in the Australian medical device company shot higher today.

    Read more »

    A guy wearing glasses tries to show off his muscles.
    Technology Shares

    Here's why the EMvision share price surged 8% on Wednesday

    Investors appear happy about an agreement EMvision has struck with tech company Keysight Technologies.

    Read more »

    A man in a white coat holds a laptop in one hand and his head in the other, it's bad news.
    Healthcare Shares

    EMvision (ASX:EMV) share price slides 5% following FDA update

    The FDA's feedback is critical in EMvision's growth narrative.

    Read more »

    Jumping asx share price represented by young girl smiling and jumping up
    Share Gainers

    EMvision (ASX:EMV) share price leaps 14% on product update

    The next step in product development has been made by EMvision...

    Read more »

    A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
    Healthcare Shares

    The EMvision (ASX:EMV) share price jumped today. Here's why

    The EMVision (ASX: EMV) share price was on the rise today following news of two technology breakthrough from the company.…

    Read more »

    a doctor looking up at question marks
    Healthcare Shares

    Why is the EMvision (ASX:EMV) share price surging 12% this week?

    The EMvision (ASX:EMV) share price is rising today, adding to significant gains on the ASX this week. Let's take a…

    Read more »

    Rising healthcare ASX share price represented by doctor giving thumbs up
    Share Market News

    Why the EMvision (ASX: EMV) share price closed 13% higher today

    The EMvision (ASX: EMV) share price finished 13% higher today after the company announced grant success. Here's the rundown.

    Read more »

    asx share price in trading halt represented by business man stopping falling row of dominoes
    Share Market News

    Why the EMvision (ASX:EMV) share price is going nowhere

    The EMvision (ASX:EMV) share price is unchanged today after the company announced a trading halt on Friday. We take a…

    Read more »

    Share Market News

    Here's why the EMvision (ASX:EMV) share price is up 9% this week

    The EMVision share price is up by almost 10% this week, after the company announced a cash injection and a…

    Read more »

    falling asx share price represented by business man wearing box on his head with a sad, crying face on it
    Share Market News

    EMvision (ASX:EMV) share price falling despite positive results

    The EMvision share price is falling lower today despite the company announcing positive results in clinical trials of its stroke…

    Read more »

    EMV ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About EMvision Medical Devices Ltd

    EMvision Medical Devices Ltd is an Australian medical device company. The company is focused on the research, development, and commercialization of medical imaging and diagnostic technology. It is seeking to commercialize a potentially low-cost, portable medical imaging device using electromagnetic microwave imaging for stroke diagnosis and monitoring and other medical imaging needs.

    EMV Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    01 Dec 2023 $1.59 $0.06 3.92% 39,821 $1.60 $1.60 $1.57
    30 Nov 2023 $1.53 $-0.10 -6.15% 2,719 $1.51 $1.53 $1.51
    29 Nov 2023 $1.63 $0.02 1.25% 15,355 $1.60 $1.66 $1.60
    28 Nov 2023 $1.60 $0.08 5.26% 35,899 $1.52 $1.60 $1.52
    27 Nov 2023 $1.52 $-0.04 -2.56% 108,836 $1.60 $1.65 $1.50
    24 Nov 2023 $1.56 $-0.05 -3.11% 28,501 $1.62 $1.62 $1.54
    23 Nov 2023 $1.61 $-0.10 -5.87% 56,943 $1.62 $1.65 $1.61
    22 Nov 2023 $1.71 $0.00 0.00% 37,519 $1.70 $1.71 $1.64
    21 Nov 2023 $1.71 $0.01 0.59% 19,442 $1.69 $1.72 $1.68
    20 Nov 2023 $1.70 $0.07 4.29% 94,802 $1.63 $1.75 $1.63
    17 Nov 2023 $1.63 $0.02 1.24% 15,475 $1.60 $1.63 $1.60
    16 Nov 2023 $1.61 $0.01 0.63% 30,938 $1.60 $1.61 $1.60
    15 Nov 2023 $1.60 $0.06 3.88% 61,633 $1.55 $1.63 $1.55
    14 Nov 2023 $1.55 $-0.10 -6.10% 7,259 $1.61 $1.61 $1.55
    13 Nov 2023 $1.64 $0.00 0.00% 7,980 $1.63 $1.64 $1.63
    10 Nov 2023 $1.64 $0.05 3.16% 19,496 $1.57 $1.64 $1.53
    09 Nov 2023 $1.58 $0.03 1.94% 69,829 $1.57 $1.66 $1.57
    08 Nov 2023 $1.55 $0.03 1.97% 34,408 $1.54 $1.60 $1.53
    07 Nov 2023 $1.53 $-0.05 -3.17% 7,182 $1.52 $1.53 $1.52
    06 Nov 2023 $1.58 $0.03 1.95% 13,135 $1.58 $1.58 $1.56

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    29 Sep 2023 Phillip Dubois Expiry 500,000 $850,000
    Options expired.
    05 May 2023 Ronald (Ron) Weinberger Cancelled 776,398 $1,234,472
    Cancellation of securities.
    05 May 2023 Ronald (Ron) Weinberger Exercise 223,602 $1,250,000
    Exercise of options. VWAP
    05 May 2023 Ronald (Ron) Weinberger Buy 223,602 $1,250,000
    Exercise of options. VWAP

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Dr Phillip James Dubois Non-Executive Director Sep 2020
    Dr Dubois is a neuroradiologist and nuclear imaging specialist, former CEO of their imaging division and served as Executive Director from 2001 to 2020. He is also the founder and former CEO and Chairman of Queensland X-Ray. Dr Dubois is currently an Associate Professor of Radiology at the University of Queensland Medical School. He has served on numerous government and radiology group bodies, including the councils of the Royal Australian and New Zealand College of Radiologists and the Australian Medical Association, and as Vice-President of the Australian Diagnostic Imaging Association.
    Dr Ronald (Ron) Peter Weinberger Non-Executive Director May 2020
    Dr Weinberger has more than 20 years' experience in medical research, biotechnology and commercialization. Dr Weinberger joined Nanosonics in August 2004 and was appointed as Executive Director in July 2008 then Managing Director and Chief Executive Officer December 2011 with a period as acting CEO from May 2011. From October 2013 to February 2018,Dr Weinberger was responsible for the direction of Nanosonics' technology development and commercialisation strategy. He is co-inventor of several of Nanosonics' key technology patents.
    Mr Anthony (Tony) Keane Non-Executive Director Jun 2018
    Mr Keane is an experienced business and finance executive and holds a number of independent non-executive director and advisory board roles.Mr Keane also undertakes finance advisory and consultancy assignments for various business clients and previously held numerous roles with a major trading bank principally in business, corporate and institutional banking.Mr Keane is currently an Independent Non-Executive Director and Chairman of National Storage Holdings Ltd, the holding company established for National Storage REIT.He is Chair of Risk Committee.
    Mr Geoffrey (Geoff) Richard Pocock Non-Executive Director Mar 2018
    Mr Geoff Pocock has experience as a corporate advisor and strategy consultant advising companies on commercialisation and IP management, business development, mergers and acquisitions strategy and raising equity capital from private and public equity markets.Mr Pocock previously spent several years as a research scientist in the biopharmaceutical industry in Australia and the United Kingdom.
    Mr John Keep Non-Executive ChairmanNon-Executive Director Mar 2018
    Mr Keep has public company board experience as well as senior management experience in the healthcare and hospitality sectors including managing start up enterprises and medical diagnostic companies. Mr Keep led the restructuring and revitalization of the radiology company Queensland Diagnostic Imaging, Queensland's leading private radiology and diagnostic imaging group and at Lemarne Healthcare, a company specialising in the detection and treatment of skin cancer.He is Member of Risk Committee.
    Mr Scott Kirkland Co-founderExecutive DirectorChief Executive OfficerManaging Director Jul 2017
    Mr Scott Kirkland has held senior sales positions,including Head of Client Sales at Quantcast, a US based technology company.Mr Kirkland is a co-founder of the Company and oversees its corporate affairs, commercial strategy and business development efforts.Mr Kirkland is a member of the Australian Institute of Company Directors.
    Ms Emma Waldon Chief Financial OfficerCompany Secretary
    Emma Waldon Chief Financial OfficerCompany Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Mr Scott Philip Kirkland 3,861,987 4.96%
    Ryan Michael Laws 3,250,000 4.17%
    Dr Ronald Peter Weinberger 2,108,727 2.71%
    Mr Paul Raymond Brown & Mrs Angelique Susan Brown<Brown Family A/C> 1,358,250 1.74%
    Jm Starcevich Investments Pty Ltd 1,230,000 1.58%
    Uniquest Pty Limited 1,200,000 1.54%
    Busso Holdings Pty Ltd <Bew A/C> 1,160,000 1.49%
    Glensburg Pty Ltd <Tyto Corp Pension Fund A/C> 1,112,000 1.43%
    Walsh Prestige Pty Ltd <Walsh Family A/C> 1,050,000 1.35%
    Dr Stuart Crozier 1,044,937 1.34%
    Mr Martin Kolev 1,000,000 1.28%
    Neweconomy Com Au Nominees Pty Limited <900 Account> 986,267 1.27%
    Mr Vincent Michael O'Sullivan <O'Sullivan A/C> 956,000 1.23%
    J P Morgan Nominees Australia Pty Limited 903,028 1.16%
    Citicorp Nominees Pty Limited 882,214 1.13%
    Wakil Family Group Pty Ltd <Ron Ton Fashions P/L Rp A/C> 860,095 1.10%
    Oofy Prosser Pty Ltd <Drones Family A/C> 855,000 1.10%
    Hillridge Pty Ltd 842,425 1.08%
    Truebell Capital Pty Ltd <Truebell Investment Fund> 840,000 1.08%
    Kong Pak Lim 805,500 1.03%